Nkarta Inc. Q4 2026 Stock Snapshot: $1.25 on Nasdaq, 52‑Week Range $1.105–$3.72Discover Nkarta Inc.’s biotech innovations in cancer & immune therapies, its current Nasdaq value and 52‑week performance trends.NKARTA INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 18/11/2026, 18:09 One minute to read